Acumen Pharmaceuticals (ABOS) Earnings Date, Estimates & Call Transcripts

$3.40
+0.04 (+1.19%)
(As of 05/8/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 14
Before Market Opens
Confirmed
Actual EPS
(Mar. 26)
-$0.29
Consensus EPS
(Mar. 26)
-$0.29
Skip Charts & View Estimated and Actual Earnings Data

ABOS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ABOS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Acumen Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.26)($0.26)($0.26)
Q2 20241($0.26)($0.26)($0.26)
Q3 20241($0.26)($0.26)($0.26)
Q4 20241($0.26)($0.26)($0.26)
FY 20244($1.04)($1.04)($1.04)

ABOS Earnings Date and Information

Acumen Pharmaceuticals last released its earnings results on March 26th, 2024. The reported ($0.29) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.29). Acumen Pharmaceuticals has generated ($1.09) earnings per share over the last year (($1.09) diluted earnings per share). Earnings for Acumen Pharmaceuticals are expected to decrease in the coming year, from ($1.22) to ($1.47) per share. Acumen Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Tuesday, May 14th, 2024. Acumen Pharmaceuticals will be holding an earnings conference call on Tuesday, May 14th at 8:00 AM Eastern. Interested parties can register for or listen to the call..

Acumen Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Confirmed)
-------  
3/26/2024Q4 2023($0.29)($0.29)-($0.29)--
11/13/2023Q3 2023($0.31)($0.24)+$0.07($0.24)--    
8/8/2023Q2 2023($0.36)($0.28)+$0.08($0.28)--
5/9/2023Q1 2023($0.33)($0.28)+$0.05($0.28)--
3/27/2023Q4 2022($0.28)($0.32)($0.04)($0.32)--    
11/14/2022Q3 2022($0.27)($0.26)+$0.01($0.26)--
8/15/2022Q2 2022($0.24)($0.25)($0.01)($0.25)--
5/16/2022Q1 2022-($0.23)($0.23)($0.23)--
11/14/2021Q3($0.17)($0.10)+$0.07($0.10)--
8/15/2021Q2 2021($0.17)($7.91)($7.74)$126.11--    

Acumen Pharmaceuticals Earnings - Frequently Asked Questions

When is Acumen Pharmaceuticals's earnings date?

Acumen Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Tuesday, May 14th, 2024. Learn more on ABOS's earnings history.

Did Acumen Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Acumen Pharmaceuticals (NASDAQ:ABOS) reported ($0.29) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.29). Learn more on analysts' earnings estimate vs. ABOS's actual earnings.

How much profit does Acumen Pharmaceuticals generate each year?

Acumen Pharmaceuticals (NASDAQ:ABOS) has a recorded net income of -$52.37 million. ABOS has generated -$1.09 earnings per share over the last four quarters.

What is Acumen Pharmaceuticals's EPS forecast for next year?

Acumen Pharmaceuticals's earnings are expected to decrease from ($1.22) per share to ($1.47) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ABOS) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners